CONMED Shares Rise on Medline's IPO, FDA Clearance
Update: 2025-12-17
Description
CONMED shares surged by 3.3% today, following Medlines successful IPO and CMR Surgicals FDA clearance for its robotic surgical system. Despite settling slightly, CONMEDs shares closed up 2.2%, reflecting investor optimism in the medical device sector. However, CONMEDs shares remain 40.5% below their yearly high.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
